Press-release for stocks published on this month related to pharma

Prices are updated after-hours

published : This month tags : Pharma

save search

Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 0.0% | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
LTRN | News | $5.44 -5.72% -6.07% 96K

Health Technology

| 0.0% | O: 2.77% H: 0.0% C: 0.0%
pharma drug key leaders development

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
Published: 2024-04-24 (Crawled : 11:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M

Health Technology

| 4.19% | O: 13.6% H: 0.0% C: 0.0%
hb-700 fda pharma drug treatment clearance for application

Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
SILO | $1.9 6.74% 6.32% 380K

Finance and Insurance

| -9.18% | O: 9.18% H: 0.47% C: -16.82%
pharma positive treatment for results

Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines
Published: 2024-04-23 (Crawled : 08:00) - prnewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma

HIV Drugs Market size is set to grow by USD 10.47 billion from 2023-2027, AbbVie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -3.74% | O: -3.15% H: 0.0% C: -0.61%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

Health Technology

| 0.98% | O: 0.0% H: 1.33% C: 0.98%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| 1.6% | O: 0.17% H: 1.48% C: 1.43%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 0.98% | O: 0.42% H: 1.06% C: 0.56%
pharma abbvie set hiv key market

Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
LTRN | News | $5.44 -5.72% -6.07% 96K

Health Technology

| 8.05% | O: 6.74% H: 5.26% C: 0.35%
lung pharma japan approval cancer cell for trial

FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
CELH | News | $71.99 -0.06% -0.06% 4.1M

Consumer Non-Durables

| 4.63% | O: 2.41% H: 1.96% C: -1.01%
pharma update

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
OCUP | News | $1.52 -1.3% -1.32% 90K

Health Technology

| -7.78% | O: -1.8% H: 0.0% C: -7.93%
apx3330 pharma presentation meeting

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 2.56% | O: 0.85% H: 0.0% C: 0.0%
pharma cancer for

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma management for

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
SBFM | $0.9263 -23.45% -28.97% 10M

Professional, Scientific, and T...

| -82.21% | O: -65.59% H: 4.7% C: -24.79%
pharma biosimilar health approval for canada

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| 3.25% | O: 0.83% H: 1.35% C: 1.2%
RPRX | $27.98 0.58% 0.57% 1.8M

Health Technology

| 0.96% | O: 1.07% H: 1.22% C: 1.11%
first pharma royalty financial results

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
LUMO | $2.795 -0.18% -0.18% 46K

Health Technology

| 11.11% | O: 5.16% H: 6.79% C: -2.26%
pharma presentation for medical

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | $0.433 -2.37% -2.42% 9K

Health Technology

| Email alert Add to watchlist
pharma key

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
EVOK | $0.433 -2.37% -2.42% 9K

Health Technology

| Email alert Add to watchlist
pharma key

Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology